Steven Pittler, Ph.D., professor in the Department of Vision Sciences in the UAB School of Optometry, has received a four-year, $1.4 million National Institutes of Health National Eye Institute grant.
This work will focus on a protein that is unique to the eye and is required for sight. When the gene that encodes this protein is defective, it leads to the ocular disorder retinitis pigmentosa, a progressive hereditary form of blindness.
Pittler, who is also director of the Vision Science Research Center, will study the function of the protein to devise treatments for the disease. The grant is titled “Analysis of retina rod photoreceptor GARP and cGMP-gated channel.”
“This application seeks to identify fundamental properties of the genes’ encoded proteins that will provide essential information needed to develop a treatment, as there is no established treatment for this disease, which affects a significant portion of the United States and world populations,” Pittler said.
Teaching metabolomics: a UAB outreach to researchers in sub-Saharan AfricaThe UAB course was part of a master’s degree program in bioinformatics for researchers in Mali, where malaria is a scourge.posted today 25 viewsUAB and Southern Research joint venture to unveil first productAIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.posted 5 days ago 625 viewsUAB Comprehensive Cancer Center awarded $29 million NCI core grantThe UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.posted 5 days ago 1102 viewsFixing cystic fibrosis: In vitro studies show therapeutically robust correction of the most common CF gene mutationCystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.posted 6 days ago 3134 viewsResearcher’s lifesaving raceways invention goes internationalUAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.posted 12 days ago 1408 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted 12 days ago 862 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted 15 days ago 2594 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted 14 days ago 2321 viewsRheumatoid arthritis: seeking an answer, cell by cellUAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.posted 19 days ago 2065 viewsA focus on homelessness as VA and UAB researchers mark National VA Research WeekVA Research support for UAB clinicians and scientists has been important for six decades.posted 20 days ago 1266 viewsRural children at risk for worse health outcomes, higher health care costsResearchers at UAB look to integrate health care within rural communities to improve care for children.posted 19 days ago 1982 views
After 30 years at UAB, VP Marchase announces plans to retireLongtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.posted 21 days ago 2424 viewsResearchers find potential breakthrough in binge-eating disorder treatmentA treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.posted 22 days ago 3377 viewsUAB Hospital recognized for decreasing inappropriate use of antibioticsAntibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.posted 25 days ago 2060 viewsTen-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted 26 days ago 2092 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 28 days ago 2473 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted a while back 3398 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted a while back 1522 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted a while back 801 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted a while back 1270 views